Syngene International

Rediff.com » News » Syngene International

News for Syngene International

Business

Govt nods 14 FDI proposals worth Rs 1,300 crore

The government said on Friday it has approved 14 FDI proposals worth about Rs 1,311 crore (Rs 13.11 billion, including that of Hindustan Port Ltd."Based on the recommendations of FIPB in its......

Global drug majors slow R&D offshoring to India

New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India.The domestic players could only manage......

Indian biotech firms on the move

Indian biotechnology firms are steadily moving up the value chain by offering research and development services for global pharma companies to aid drug discovery and manufacture.Companies are......

Ranbaxy deal: Let's look for a business model

In the early nineties, the major Indian pharma companies, particularly the top two, Ranbaxy and Dr Reddy's, took a major far-sighted decision. Led by Parvinder Singh and Anji Reddy, respectively,......

Indian may have found cure to HIV

A cure for the deadly human immunodeficiency virus (HIV) infection might well be much closer than the world thought earlier. In a significant breakthrough, a group of scientists -- including an......

Web results for Syngene International

Kiran Mazumdar-Shaw

Biocon's fourth quarter results seemed to disappoint the market; the company vigorously defended its strategy. Kiran Mazumdar-Shaw, chairman and... ...

http://www.sify.com/finance/we-re-bullish-on-meeting-targets-kiran-mazumdar-shaw-news-default-ne1eltfiagj.html

Biocon's Syngene emerges as India's largest CRO & Asia's 2nd after Wuxi, set to go public

Biocon's research services arm Syngene International is now India's largest contract research organization in the country and the second in Asia... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=75036&sid=2

Biocon delivers a strong performance of 18% Revenue Growth in FY13 driven by an evolving Product Portfolio & Research Services

Biopharma: Small Molecules & Biosimilars Small Molecules The small molecules portfolio was driven by strong sales in Fidaxomicin &... ...

http://webnewswire.com/content/biocon-delivers-strong-performance-18-revenue-growth-fy13-driven-evolving-product-portfolio

Top 10 Indian life science collaborations of 2012

Biospectrum In today's rapidly evolving pharma market, firms are relying on efficient collaboration strategies in order to counter... ...

http://www.biospectrumasia.com/biospectrum/news/185905/top-indian-life-science-collaborations-2012

Anthem infuses Rs.100 cr to get into bio-pharma products from its dedicated 2nd unit

Anthem Group has planned an investment of Rs.100 crore to open its second production facility at the Harohalli Industrial Area in Bengaluru. The... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=74358&sid=1

See All

Rediff News

Syngene International

News for Syngene International

Govt nods 14 FDI proposals worth Rs 1,300 crore

Global drug majors slow R&D offshoring to India

Indian biotech firms on the move

Ranbaxy deal: Let's look for a business model

Indian may have found cure to HIV

Top Coverage News

Indian Premier League - IPL 2013

Coverage: The Match-Fixing Episode II - spot-fixing trial

Sachin Tendulkar : Cup of praise overfloweth - Reactions

Complete coverage of Mumbai blasts

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog